Evidence map›Paper›PMID 37628970›Full record

ArticleInternational journal of molecular sciences2023

A Comparative Study on the Lysosomal Cation Channel TMEM175 Using Automated Whole-Cell Patch-Clamp, Lysosomal Patch-Clamp, and Solid Supported Membrane-Based Electrophysiology: Functional Characterization and High-Throughput Screening Assay Development.

Andre Bazzone, Maria Barthmes, Cecilia George, Nina Brinkwirth, Rocco Zerlotti, Valentin Prinz, Kim Cole, Søren Friis, Alexander Dickson, Simon Rice and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Proton-selective conductance and gating of the lysosomal cation channel TMEM175.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Targeting TMEM175 in Lysosomal Physiology and Human Diseases.Current stem cell research & therapy · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. The Role of Ion-Transporting Proteins in Human Disease.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Andre BazzoneNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.ORCID 0000-0002-2419-3519
Maria BarthmesNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.
Cecilia GeorgeNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.
Nina BrinkwirthNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.
Rocco ZerlottiNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.
Valentin PrinzNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.
Kim ColeNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.
Søren FriisNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.
Alexander DicksonSB Drug Discovery, West of Scotland Science Park, Glasgow G20 0XA, UK.
Simon RiceSB Drug Discovery, West of Scotland Science Park, Glasgow G20 0XA, UK.
Jongwon LimCerevel Therapeutics, 222 Jacobs St, Cambridge, MA 02141, USA.ORCID 0000-0003-3402-7810
May Fern TohCerevel Therapeutics, 222 Jacobs St, Cambridge, MA 02141, USA.ORCID 0000-0002-6136-4639
Milad MohammadiAssay Works, Am BioPark 11, 93053 Regensburg, Germany.
Davide PauSB Drug Discovery, West of Scotland Science Park, Glasgow G20 0XA, UK.
David J StoneCerevel Therapeutics, 222 Jacobs St, Cambridge, MA 02141, USA.
John J RengerCerevel Therapeutics, 222 Jacobs St, Cambridge, MA 02141, USA.
Niels FertigNanion Technologies, Ganghoferstr. 70a, 80339 Munich, Germany.ORCID 0000-0002-9731-2283
Nanion (Germany) · DEJacobs (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lysosomal cation channel TMEM175 is a Parkinson's disease-related protein and a promising drug target. Unlike whole-cell automated patch-clamp (APC), lysosomal patch-clamp (LPC) facilitates physiological conditions, but is not yet suitable for high-throughput screening (HTS) applications. Here, we apply solid supported membrane-based electrophysiology (SSME), which enables both direct access to lysosomes and high-throughput electrophysiological recordings. In SSME, ion translocation mediated by TMEM175 is stimulated using a concentration gradient at a resting potential of 0 mV. The concentration-dependent K

Indexed as

Cardiac ElectrophysiologyHigh-Throughput Screening AssaysCationsLysosomesMembrane PotentialsCationsautomated patch-clamp (APC)drug developmention channelslysosomal patch-clamplysosomesParkinson’s disease (PD)screening technologiessolid supported membrane-based electrophysiology (SSME)SURFE2RTMEM175

Identifiers

PMID37628970
PMCPMC10454728
OpenAlexW4385795855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.